Alvin H. Schmaier, of the Department of Pathology, explains how certain anticoagulants could aid patients at risk of developing thrombosis

Anticoagulation Is Key for Adjunctive Therapy in Thrombosis Management

OncLive: Alvin H. Schmaier, a professor in the Department of Medicine and the Department of Pathology, discussed the primary and secondary management of cancer-related thrombosis, explaining that patients at risk of developing thrombosis should receive certain anticoagulants to control excessive bleeding: “When you give an anticoagulant in the current era, it’s a balance between preventing clots, but not giving [too much] anticoagulation in that patients hemorrhage. That’s the major complication,” said Schmaier. “To address that, we now have antidotes to [specific] inhibitors.”